#1 Clinical Trials Search in Europe

Metoclopramide

Metoclopramide is a medication that has been the subject of numerous clinical trials, investigating its effectiveness in treating various medical conditions. These trials have explored its use in areas such as diabetic gastroparesis, migraine, labor duration, gastric transit time, myelodysplastic syndrome, bariatric surgery, and upper gastrointestinal bleeding. The studies aim to determine the drug’s efficacy, optimal dosing, and potential side effects in different patient populations.

Table of Contents

What is Metoclopramide?

Metoclopramide is a medication that belongs to a class of drugs known as antiemetics and prokinetics. It is commonly used to treat various gastrointestinal disorders and symptoms related to nausea and vomiting. Metoclopramide is also known by several brand names, including Reglan, Primperan, Metpamid, and Metadem[1].

Uses of Metoclopramide

Metoclopramide is prescribed for several conditions and symptoms, including:

  • Nausea and vomiting: It is effective in treating nausea and vomiting associated with various conditions, such as pregnancy, chemotherapy, and surgery[2].
  • Migraine headaches: Metoclopramide can help alleviate nausea associated with migraines and may also have pain-relieving effects[3].
  • Gastroparesis: This is a condition where the stomach takes too long to empty its contents. Metoclopramide can help improve stomach emptying in patients with diabetic gastroparesis[4].
  • Gastroesophageal reflux disease (GERD): The medication may be used to treat symptoms of GERD by improving stomach emptying.
  • Facilitating medical procedures: Metoclopramide can be used to improve visualization during upper gastrointestinal endoscopy procedures[5].

How Metoclopramide Works

Metoclopramide works in several ways to provide its therapeutic effects:

  1. Antiemetic action: It blocks dopamine receptors in an area of the brain called the chemoreceptor trigger zone, which helps reduce nausea and vomiting[2].
  2. Prokinetic action: Metoclopramide enhances the movement of the stomach and small intestine, which helps in faster emptying of stomach contents and improves digestion[4].
  3. Serotonin receptor antagonism: It may also work by blocking certain serotonin receptors in the gut, which can contribute to its anti-nausea effects[2].

Administration and Dosage

Metoclopramide can be administered in various forms, including:

  • Oral tablets: Regular tablets or orally disintegrating tablets that dissolve in the mouth[4].
  • Intravenous (IV) injection: Given directly into a vein, often used in hospital settings for quick relief of symptoms[6].
  • Intramuscular (IM) injection: Injected into a muscle, sometimes used for faster absorption compared to oral administration[7].

The dosage of metoclopramide varies depending on the condition being treated, the patient’s age, and other factors. It’s crucial to follow your healthcare provider’s instructions carefully and not exceed the recommended dose.

Potential Side Effects

While metoclopramide can be effective for many patients, it may cause some side effects. Common side effects may include:

  • Drowsiness or tiredness
  • Dizziness
  • Restlessness or agitation
  • Headache
  • Diarrhea

In rare cases, metoclopramide may cause more serious side effects, such as movement disorders. It’s important to inform your healthcare provider if you experience any unusual symptoms while taking this medication[8].

Ongoing Research

Researchers continue to study metoclopramide for various potential uses:

  • Anemia in myelodysplastic syndrome (MDS): Some studies are investigating whether metoclopramide can improve red blood cell counts in patients with MDS, a group of disorders affecting blood cell production[8].
  • Labor and delivery: Research is being conducted to determine if metoclopramide can help shorten the duration of labor in pregnant women[7].
  • Premature infants: Studies are exploring the use of metoclopramide to improve feeding in very low birth weight newborns[9].

These ongoing studies may lead to new approved uses for metoclopramide in the future, potentially benefiting more patients with various conditions.

Aspect Details
Conditions Studied Diabetic gastroparesis, migraine, labor duration, gastric transit time, myelodysplastic syndrome, bariatric surgery, upper gastrointestinal bleeding
Administration Methods Oral tablets, orally disintegrating tablets, intravenous, intramuscular
Dosages Varying from 10 mg to 40 mg, depending on the study
Primary Outcomes Improved gastric emptying, reduced migraine pain, shortened labor duration, increased gastric transit time, improved anemia, better endoscopic visualization
Comparison Drugs Placebo, hyoscine butylbromide, dexketoprofen trometamol, dimenhydrinate
Patient Populations Adults with various conditions, including diabetics, pregnant women, surgical patients
Study Designs Randomized controlled trials, double-blind studies, crossover trials

FAQ

  • What is metoclopramide used for in clinical trials? Metoclopramide is being studied for various conditions, including diabetic gastroparesis, migraine, labor duration, gastric transit time, myelodysplastic syndrome, bariatric surgery, and upper gastrointestinal bleeding.
  • How is metoclopramide administered in these trials? Depending on the study, metoclopramide is administered in different ways, including orally as tablets or orally disintegrating tablets, intravenously, or intramuscularly.
  • What are some potential benefits of metoclopramide being studied? Potential benefits being studied include improved gastric emptying, reduced migraine pain, shortened labor duration, increased gastric transit time, improved anemia in myelodysplastic syndrome, and better endoscopic visualization in upper gastrointestinal bleeding.
  • Are there any side effects of metoclopramide mentioned in these trials? While specific side effects are not detailed in the trial summaries, some studies mention monitoring for adverse events. Common side effects of metoclopramide can include drowsiness, dizziness, and fatigue.
  • How long do these clinical trials typically last? The duration of the trials varies widely, from single-dose studies lasting a few hours to longer-term studies lasting several weeks or months, depending on the condition being studied and the specific trial design.

Ongoing Clinical Trials on Metoclopramide

  • Study Comparing Short-Course Radiotherapy and Drug Combination for Older Patients with Locally Advanced Rectal Cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Study on Meniere’s Disease: Comparing Methylprednisolone and Placebo for Patients with Unilateral Meniere’s Disease

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Gastroparesis: A condition that affects the normal movement of muscles in the stomach, preventing proper emptying of the stomach contents.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Orally Disintegrating Tablet: A tablet that quickly dissolves in the mouth without the need for water.
  • Migraine: A type of headache characterized by severe pain, often accompanied by nausea and sensitivity to light and sound.
  • Myelodysplastic Syndrome (MDS): A group of disorders caused by poorly formed or dysfunctional blood cells.
  • Gastric Residual Volume (GRV): The amount of liquid contents remaining in the stomach after a period of time.
  • Bariatric Surgery: Surgical procedures performed on the stomach or intestines to induce weight loss in severely obese individuals.
  • Upper Gastrointestinal Bleeding: Bleeding that occurs in the upper part of the digestive tract, including the esophagus, stomach, and first part of the small intestine.
  • Visual Analogue Scale (VAS): A measurement instrument used to assess subjective characteristics or attitudes that cannot be directly measured.
  • Antiemetic: A drug that is effective against vomiting and nausea.

References

  1. https://clinicaltrials.gov/study/NCT02253524
  2. https://clinicaltrials.gov/study/NCT01781377
  3. https://clinicaltrials.gov/study/NCT00682734
  4. https://clinicaltrials.gov/study/NCT00139893
  5. https://clinicaltrials.gov/study/NCT06297954
  6. https://clinicaltrials.gov/study/NCT04252521
  7. https://clinicaltrials.gov/study/NCT05222646
  8. https://clinicaltrials.gov/study/NCT00120653
  9. https://clinicaltrials.gov/study/NCT00242450